| Prev Close | 2.10 |
| Day Low/High | 2.00 / 2.14 |
| 52 Wk Low/High | 1.38 / 3.85 |
Recro Pharma, Inc. (REPH)
2.09
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 56.42B |
| Market Cap | 118.49M |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
There's Some Market Choppiness and Inconsistency That's Quite Challenging
I continue to hunt for buys but I am staying highly selective which can make you feel left out when the market is acting this frothy.
3 Small Biotechs With Potential Catalysts at Hand
Esperion Therapeutics, Agenus Inc. and Baudax Bio could see coming events trigger positive reactions in their shares.
How Am I Doing? An Update on My Top 6 Stock Picks for 2020
I've previously discussed why these six stocks are my top picks for 2020. I will periodically provide updates and discuss my strategy for trading them.
This Is a Very Tough Market for Stock Picking
The higher this market goes the more that many market players wonder how much longer it can last.
I'm Adding This Pharma Company to My Top Stocks for 2020 List
Recro Pharma Inc., which makes drugs such as Ritalin LA for Novartis, looks healthy going into 2020.
Healthy Upside Potential In Medical Devices and Services Stocks
Some of the best opportunities are in lesser-known niche markets such as medical devices and services.
Focus on the Trees, Not the Forest
The current market favors stock pickers.
In This Market, Err on the Side of Caution
The selling appears a healthy digestion and we've likely yet to see the indexes reach their highs for the year, but traders should still tread carefully.
This Market Is Ripe for Some Healthy Consolidation
Small-cap earnings season is just starting, which is good for stock pickers.
Stocks Trading in Very Sloppy Fashion Ahead of the FOMC Announcement
When trading in front of the Fed the focus must be much more defensive than offensive.
Time for a Reality Check: Big Winners Aren't Cheap
We all want a bargain -- meaning we pay less than the highest price -- but that thinking doesn't work with stocks.
The Strong Small-Cap Group Is Keeping Me Optimistic
The momentum in the broader market is not that strong and the rotational issue continues.
9 Stocks on My Radar Into Earnings
Don't be too quick to turn negative if there are some pullbacks.
There Are Signs of Improved Technical Action and Stock Picking
China trade issue is no longer dominating the action.
2 Stocks on My Radar in a Low-Energy Market
Flat markets tend to produce favorable technical setups, but this one may put us to sleep while we wait for further developments.
Risk of Further Market Downside Is Very High Here
These buyers are most likely to be flippers and they will exit fast and kill the bounce tries.
Here Are 6 Small-Caps on My Radar
I'm optimistic that we will see some better stock picking action if the breakout holds and momentum continues.
Dealing With Biotech Stocks That Face Setbacks
Knowing when to continue to fish or cut bait is something that develops over time in this space.
Gold Stocks Are Positive on a Negative Day: Here Are My 2 Favorites
While today's action isn't attractive, we were ripe for a little profit-taking.